Patents
Clinically Intelligent Diagnostic Devices and MethodsIssued Patents: 08/16/2011 US 7,998,679 (United States) 11/24/2009 US 7,622,250 07/28/2009 US 7,566,533 06/14/2005 US 6,905,816 11/12/2008 JP 4179876 (Japan) 01/20/2010 EP 1397679 (Europe)
Published Applications: 12/22/2011 US 2011/0312531 06/30/2010 EP 2202520 02/17/2003 AU 3052302 (Australia) 05/30/2002 WO 2002/042775 05/30/2002 CA 2430110 (Canada)
Methods and Systems for Designing Primers and ProbesPublished Applications: 11/08/2007 US 2007/0259337 06/07/2007 WO 2007/064758 08/27/2008 EP 1960555 06/07/2007 CA 2632380 06/07/2007 AU 2006320541 04/30/2009 JP 2009/517087
Optimized Probes and Primers and Methods of Using Same for the Detection, Quantitation, Isolation and Sequencing of Cytomegalovirus and Epstein-Barr VirusPublished Applications: 11/25/2010 US 2010/0297612 01/27/2011 WO 2010/135514 Optimized Probes and Primers and Method of Using Same for the Detection of Herpes Simplex VirusPublished Applications: 01/20/2011 US 2011/0014598 01/07/2010 WO 2009/089257 10/20/2010 EP 2240503
Optimized Probes and Primers and Methods of Using Same for the Detection and Quantification of BK Virus
Published Applications: 10/01/2009 US 2009/0246754 11/12/2009 WO 2009/137137 12/08/2010 EP 2257648
Optimized Probes and Primers and Methods of Using Same for the Detection, Quantification and Grouping of HIV-1Published Applications: 10/15/2009 US 2009/0258342 12/30/2009 WO 2009/126517
Optimized Oligonucleotides and Methods of Using Same for the Detection, Isolation, Quantification, Monitoring and Sequencing of BordetellaPublished Applications: 12/20/2010 US 2010/0330573 03/10/2011 WO 2010/151771
Optimized Probes and Primers and Methods of Using Same for the Detection, Screening, Isolation and Sequencing of Vancomycin Resistance Genes and Vancomycin Resistant Enterococci
Published Applications: 08/18/2011 US 2011/0200995 09/29/2011 WO 2011/029034
Optimized Probes and Primers and Methods of Using Same for the Binding, Detection, Differentiation, Isolation and Sequencing of Influenza A; Influenza B; 2009 Influenza A/H1N1; and a 2009 Influenza A/H1N1 RNA Sequence Mutation Associated with Oseltamivir ResistancePublished Application: 10/13/2011 US 2011/0250583 06/03/2011 WO 2011/035322
Optimized Oligonucleotides and Methods of Using Same for the Detection, Isolation, Amplification, Quantification, Monitoring, Screening and Sequencing of Clostridium Difficile Genes Encoding Toxin B, and/or Toxin A and/or Binary ToxinPublished Application: 10/20/2011 US 2011/0256535 08/18/2011 WO 2011/100443
Optimized Oligonucleotides and Methods of Using Same for the Screening, Detection, Isolation, Quantitation, Monitoring and Sequencing of Prostate Cancer Associated Viruses and Host BiomarkersPublished Application: 10/20/2011 US 2011/0256537 10/20/2011 WO 2011/130273
Optimized Probes and Primers and Methods of Using Same for the Detection, Screening, Isolating and Sequencing of MRSA, MSSA, Staphylococcus Markers, and the Antibiotic Resistance Gene MecAPublished Application: 12/15/2011 US 2011/0306510
Optical Determination of In Vivo PropertiesIssued Patent: 05/29/2007 US 7,225,005
|